Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice
Publication Date: September 1, 2019
Last Updated: December 15, 2022
Diagnosis
Table 2. Recommendations
Invasive fungal disease
In patients with severe immune compromise, such as those with neutropenia, hematologic malignancy or recipients of hematologic stem cell or solid organ transplants presenting with unexplained lung infiltrates suspected of invasive fungal disease, the ATS recommends the use of serum GM testing. (S, H)
620
Title
Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice
Authoring Organization
American Thoracic Society